Van Eck Associates Corp Edwards Lifesciences Corp Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 126,764 shares of EW stock, worth $8.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

126,764

Previous 117,753 7.65%

Holding current value

$8.59 Million

Previous $10.9 Million 17.71%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$59.7 - $93.78 $537,956 - $845,051	9,011 Added 7.65%	126,764 $8.95 Million
Q2 2024 Jul 31, 2024	SELL	$84.3 - $94.31 $2.05 Million - $2.29 Million	-24,329 Reduced 17.12%	117,753 $10.9 Million
Q1 2024 Apr 30, 2024	SELL	$72.54 - $95.56 $2.03 Million - $2.68 Million	-28,012 Reduced 16.47%	142,082 $13.6 Million
Q4 2023 Feb 05, 2024	BUY	$61.71 - $77.76 $1.52 Million - $1.91 Million	24,605 Added 16.91%	170,094 $13 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $1.22 Million - $1.64 Million	17,597 Added 13.76%	145,489 $10.1 Million
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $645,825 - $748,319	-7,933 Reduced 5.84%	127,892 $12.1 Million
Q1 2023 May 03, 2023	BUY	$74.26 - $84.51 $913,026 - $1.04 Million	12,295 Added 9.95%	135,825 $11.2 Million
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $455,970 - $583,749	6,676 Added 5.71%	123,530 $9.22 Million
Q3 2022 Oct 27, 2022	BUY	$82.37 - $107.29 $500,891 - $652,430	6,081 Added 5.49%	116,854 $9.66 Million
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $179,833 - $266,673	-2,079 Reduced 1.84%	110,773 $10.5 Million
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $1.79 Million - $2.25 Million	17,512 Added 18.37%	112,852 $13.3 Million
Q4 2021 Jan 26, 2022	BUY	$106.37 - $130.68 $1.71 Million - $2.1 Million	16,084 Added 20.29%	95,340 $12.4 Million
Q3 2021 Nov 03, 2021	BUY	$102.91 - $122.75 $1.64 Million - $1.95 Million	15,924 Added 25.14%	79,256 $8.97 Million
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $25,655 - $32,056	306 Added 0.49%	63,332 $6.56 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $538,721 - $620,817	6,847 Added 12.19%	63,026 $5.27 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $591,442 - $752,647	8,250 Added 17.21%	56,179 $5.13 Million
Q3 2020 Dec 04, 2020	BUY	$67.19 - $87.44 $3.22 Million - $4.19 Million	47,929 New	47,929 $3.83 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $2.83 Million - $3.69 Million	-42,187 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $1.76 Million - $2.36 Million	30,606 Added 264.28%	42,187 $2.92 Million
Q1 2020 May 12, 2020	BUY	$52.41 - $81.0 $59,747 - $92,340	1,140 Added 10.92%	11,581 $2.18 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $675,127 - $772,959	9,416 Added 918.63%	10,441 $2.44 Million
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $10,032 - $12,295	163 Added 18.91%	1,025 $225,000
Q2 2019 Aug 07, 2019	BUY	$55.74 - $64.41 $48,047 - $55,521	862 New	862 $159,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Edwards Lifesciences Corp Transaction History